Arecor Therapeutics (AREC)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 76.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 199.00
  • 52 Week Low: 66.00
  • Currency: UK Pounds
  • Shares Issued: 37.76m
  • Volume: 413
  • Market Cap: £28.88m
  • Beta: 0.09

AREC Overview

Arecor is a globally focused biopharmaceutical company that is targeting improving patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying the Group's innovative proprietary formulation technology platform, Arestat™, the Group is developing an internal portfolio of proprietary products, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their partners' therapeutic products, supported by an extensive patent portfolio.
Competitors: Yourgene Health

Key Personnel

CEO: Sarah Jennifer Howell
CFO: David Ellam
Independent Non-Executive Director: Christine Helen Soden
Independent Non-Executive Director: Jeremy Lewis Morgan
Independent Non-Executive Director: Mohammed Sohail Fazeli
Non-Executive Chairman: Andrew Richards
Non-Executive Dir: Alan Edward Smith

Contact Details

Address: Chesterford Research Park, Little Chesterford, Saffron Walden, United Kingdom, CB10 1XL
Phone: +44 (0)1223 426060
Website: https://arecor.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BMWLM973

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AREC Market Data

Currency UK Pounds
Share Price 76.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 199.00
52 Week Low 66.00
Volume 413
Shares Issued 37.76m
Market Cap £28.88m
Beta 0.09

AREC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.6% below the market average53.6% below the market average53.6% below the market average53.6% below the market average53.6% below the market average
Sector averageSector averageSector averageSector averageSector average
Price Trend
87.11% below the market average87.11% below the market average87.11% below the market average87.11% below the market average87.11% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Income Not Available
Growth
59.12% above the market average59.12% above the market average59.12% above the market average59.12% above the market average59.12% above the market average
64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average

AREC Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
11:00 392 @ 73.50p
11:00 392 @ 73.50p
09:00 20 @ 73.50p
09:00 20 @ 73.50p
08:15 1 @ 78.00p

AREC Key Personnel

CEO Sarah Jennifer Howell
CFO David Ellam

Top of Page